Information sources promotional

Prescription-only drugs can only be promoted or advertised in technical publications or information sources intended exclusively for doctors and other health workers. 

Information available to healthcare professionals Promotional material must be accessible to healthcare professionals only via a secure system that is designed to prevent access by members of the general public. Companies must take all reasonable steps to ensure that these information sources are appropriate and will enhance the appropriate prescribing, dispensing and usage of medicines in Australia. Any promotional material provided to healthcare professionals via the internet must comply with the requirements for other promotional items. 

AHRQ will promote the use of information systems to develop and disseminate performance measures, create effective linkages between health information sources to enhance healthcare delivery and coordinate evidence-based healthcare services, and promote protection of individually identifiable patient information used in health services research and healthcare quality improvement. 

Pharmacists should be aware of the differences in safety standards and regulatory control between drugs and dietary supplements (Table 1). When counseling people about dietary products, pharmacists must be aware that the DSHEA allows the promotion of substances that may have variable potency, unidentified components, unproven efficacy, and unknown adverse effects. The DSHEA does not require warnings about drug interactions or medical conditions under which a dietary supplement should not be used. In view of the liberal labeling provisions of the DSHEA, pharmacists cannot trust dietary supplement company literature and should consult reliable information sources (Table 2)." ... 

The Environmental Agency of Japan has conducted questionnaire surveys on the emission of air pollutants from stationary sources every three years, in order to obtain information for promotion of air pollution control policy. Based on the results of these surveys, together with the data on emission factors for mobile and other sources, the emission trends for SO2 and NO are shown in Table 5. 

Information source US Army Center for Health Promotion and Preventative Medidne. Industrial Chemical Prioritization and Determination of Critical Hazards of Concern. Aberdeen Proving Ground, Md USACHPPM 2003 Appendix B. USACHPPM Report 47-EM-6154-03 S short, L long, / intermediate... 

The farmer and restaurant may work together to promote the produce used. For example, the restaurant could provide leaflets containing information on the produce, farm source and animal welfare. 

The UNIDO program links existing sources of information on low and nonwaste technologies and promotes cleaner production worldwide through four primary activities the International... 

A patent, therefore, encourages innovation by promoting research and development. It can also be regarded as a physical asset, which can be sold or licensed to third parties for cash. Patents also represent a unique source of technical information regarding the patented product. 

If the client consents to involvement of family or friends, they can be good sources for information that can help you devise a thoughtful treatment plan. As mentioned earlier in this chapter, people with drug problems may have relationship stressors that need to be addressed in order to promote a successful treatment outcome. Being able to gather information from partners or friends about the nature of these stressors adds another dimension to understanding the source and treatment for the problems. Sometimes a family member or friend has a different view on the nature of a problem or on the behavior pattern related to a problem that may help you better understand how to treat it. 

Pollution Prevention Act of 1990 makes it the national policy of the United States to reduce or eliminate the generation of waste at the source whenever feasible and directs the EPA to undertake a multimedia program of information collection, technology transfer, and financial assistance to the states to implement this policy and to promote the use of source reduction techniques. 

It should always be remembered that the IB is not a promotional document aimed at presenting the NME in its best light on the contrary, it is intended to inform investigators and ethics committees about every aspect of the drug, to enable them to make wise judgements in the interest of study subjects, be they healthy volunteers or patients. The IB is necessarily a summary, but less than full disclosure of important information about the drug, whatever the source, is not acceptable and all documents should be referenced and made available on request. 

The dissemination of information to the scientific commimity is essential for the progress of research. Publications in scientific journals provide a key source of information. In the case of medical research, patients lives may be at stake. There are other reasons for publication. Publication will provide prestige to the investigator, to the sponsor and to the institutions involved in the research. In addition, in some circumstances the published paper will be quoted in reference dictionaries and pharmacopoeia, in advertisements and other promotions. The pharmaceutical physician should take every opportunity to publish high-quality scientific papers, even if the findings are not sensational but provide useful additional information. 

---